Cerba Research Experts to Address CGT Analytical Bottlenecks

On September 30, 2026, Kirsty Maclean and Karthikeyan Devaraju of Cerba Research will host a session focused on synchronizing flow cytometry, genomics, and bioanalytical testing. The discussion centers on moving beyond single-modality assessments to create a cohesive view of cellular phenotype, genetic modifications, and therapeutic potency. By integrating these disparate data streams, developers can better address the unique challenges posed by CAR-T, hematopoietic stem cell, and AAV-based therapies.

Beyond the scientific hurdles, the presenters will tackle the logistical realities of global clinical trials. Ensuring assay standardization and data consistency across international sites remains a primary friction point for sponsors aiming to scale their programs. The session provides a framework for managing these complexities, offering strategies to reduce development risk and streamline the path from molecular design to commercialization.